Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
| Autor: | Nitish Badhwar, Randall J. Lee, Remo L. Morelli, Duong Le |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Septal Occluder Device medicine.medical_treatment Embolism macromolecular substances Left atrial appendage occlusion Prosthesis Implantation Left atrial Internal medicine Atrial Fibrillation Internal Medicine medicine Humans Atrial Appendage In patient cardiovascular diseases Ligation Oral anticoagulation Cardioembolic stroke business.industry Patient Selection Warfarin Anticoagulants Thrombosis Atrial fibrillation General Medicine medicine.disease Stroke Stroke prevention Cardiology Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | Expert Review of Cardiovascular Therapy. 13:907-914 |
| ISSN: | 1744-8344 1477-9072 |
| DOI: | 10.1586/14779072.2015.1057123 |
| Popis: | The most severe consequence of atrial fibrillation (AF) is a cardioembolic stroke. The incidence of cardioembolic stroke increases significantly in patients with AF. Although warfarin has been the mainstay of the prevention of cardioembolic stroke, there are several limitations to the use of warfarin that hinder its effectiveness. This article provides the historical development of devices that exclude the left atrial appendage, their effectiveness and potential patient selection, as an alternative to warfarin and the novel oral anticoagulation therapy for the prevention of cardioembolic stroke in patients with AF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|